Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Kidney Neoplasms × Axitinib × Clear all

Phase

Status

Completed 8 Recruiting 3 Unknown 1 Terminated 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Uterine Cervical Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Kidney Neoplasms 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Cystadenocarcinoma, Serous 1 Clear-cell metastatic renal cell carcinoma 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Merkel Cell 1

Interventions

Cyclophosphamide 9 fludarabine 8 Interleukin-2 7 aldesleukin 6 Everolimus 6 Bevacizumab 6 fludarabine phosphate 5 Sunitinib 5 Sorafenib 5 Nivolumab 4 Gene Expression Profiling 4 Filgrastim 4 pembrolizumab 3 peginterferon alfa-2b 3 Stem Cell Transplantation 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Melphalan 3 Immunohistochemistry 3 Granulocyte Colony-Stimulating Factor 3 cabozantinib 2 atezolizumab 2 Thiotepa 2 Sodium Chloride 2 Reverse Transcriptase Polymerase Chain Reaction 2 Polymerase Chain Reaction 2 Mycophenolic Acid 2 Mesna 2 Immunoenzyme Techniques 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01649180 2021-08-12

PrE0801

PrECOG, LLC.

Phase 2 Terminated

3 enrolled 7 charts

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡